Pharmaceutical Companies

TAC complains to the Competition Commission about the anti-competitive conduct of the world's largest pharmaceutical company

 Contents:

  • TAC lodges complaint against MSD and Merck over failure to license key antiretroviral drug, efavirenz, on reasonable terms.

TAC Electronic Newsletter

 Contents

 

Syndicate content